MDR 2017/745 Specialist
EU MDR 2017/745 compliance specialist for medical device classification, technical documentation, clinical evidence, and post-market surveillance.
How to use it
Claude Code
- Run the line below. It pulls the whole folder into
~/.claude/skills/mdr-745-specialist. - Describe your job in plain words. Claude Code follows the skill from there.
npx degit alirezarezvani/claude-skills/ra-qm-team/skills/mdr-745-specialist#main ~/.claude/skills/mdr-745-specialistFor one project only, change the path to .claude/skills/mdr-745-specialist.
Claude (web or desktop app)
- On this page open ⋯ → Download .md.
- Save it as SKILL.md in a folder, zip the folder, then Customize → Skills → + → Create skill → Upload a skill.
- Pick the file and Save. Claude shows the name and description and runs a security scan.
- Check the skill is switched on.
- Start a new chat and describe your job in plain words. The AI follows the skill from there.
ChatGPT or another app
- ChatGPT: make a Project and paste it into Instructions.
- Neither? Paste it at the top of a new chat — it works for that chat.
Not working?
- Check which app you pasted it into — the steps above name the right one.
- Some skills need the paid tier of Claude or ChatGPT.
Paste into Claude, ChatGPT or Cursor.
Source of MDR 2017/745 Specialist
Show the full text336 lines
| name | description | triggers |
|---|---|---|
| mdr-745-specialist | EU MDR 2017/745 compliance specialist for medical device classification, technical documentation, clinical evidence, and post-market surveillance. Covers Annex VIII classification rules, Annex II/III technical files, Annex XIV clinical evaluation, Art. 86 PSUR schedules, and EUDAMED integration. Use when classifying a medical device under MDR, building or gap-checking a technical file, planning clinical evaluation or PMS/PSUR cadence, or preparing for notified body review (e.g., 'what class is my device under MDR', 'review my PSUR schedule'). | - MDR compliance - EU MDR - medical device classification - Annex VIII - technical documentation - clinical evaluation - PMCF - EUDAMED - UDI - notified body |
MDR 2017/745 Specialist
EU MDR compliance patterns for medical device classification, technical documentation, and clinical evidence.
Table of Contents
- Device Classification Workflow
- Technical Documentation
- Clinical Evidence
- Post-Market Surveillance
- EUDAMED and UDI
- Reference Documentation
- Tools
Device Classification Workflow
Classify device under MDR Annex VIII:
- Identify device duration (transient, short-term, long-term)
- Determine invasiveness level (non-invasive, body orifice, surgical)
- Assess body system contact (CNS, cardiac, other)
- Check if active device (energy dependent)
- Apply classification rules 1-22
- For software, apply MDCG 2019-11 algorithm
- Document classification rationale
- Validation: Classification confirmed with Notified Body
Classification Matrix
| Factor | Class I | Class IIa | Class IIb | Class III |
|---|---|---|---|---|
| Duration | Any | Short-term | Long-term | Long-term |
| Invasiveness | Non-invasive | Body orifice | Surgical | Implantable |
| System | Any | Non-critical | Critical organs | CNS/cardiac |
| Risk | Lowest | Low-medium | Medium-high | Highest |
Software Classification (MDCG 2019-11)
| Information Use | Condition Severity | Class |
|---|---|---|
| Informs decision | Non-serious | IIa |
| Informs decision | Serious | IIb |
| Drives/treats | Critical | III |
Classification Examples
Example 1: Absorbable Surgical Suture
- Rule 8 (implantable, long-term)
- Duration: > 30 days (absorbed)
- Contact: General tissue
- Classification: Class IIb
Example 2: AI Diagnostic Software
- Rule 11 + MDCG 2019-11
- Function: Diagnoses serious condition
- Classification: Class IIb
Example 3: Cardiac Pacemaker
- Rule 8 (implantable)
- Contact: Central circulatory system
- Classification: Class III
Technical Documentation
Prepare technical file per Annex II and III:
- Create device description (variants, accessories, intended purpose)
- Develop labeling (Article 13 requirements, IFU)
- Document design and manufacturing process
- Complete GSPR compliance matrix
- Prepare benefit-risk analysis
- Compile verification and validation evidence
- Integrate risk management file (ISO 14971)
- Validation: Technical file reviewed for completeness
Technical File Structure
ANNEX II TECHNICAL DOCUMENTATION
├── Device description and UDI-DI
├── Label and instructions for use
├── Design and manufacturing info
├── GSPR compliance matrix
├── Benefit-risk analysis
├── Verification and validation
└── Clinical evaluation report
GSPR Compliance Checklist
| Requirement | Evidence | Status |
|---|---|---|
| Safe design (GSPR 1-3) | Risk management file | ☐ |
| Chemical properties (GSPR 10.1) | Biocompatibility report | ☐ |
| Infection risk (GSPR 10.2) | Sterilization validation | ☐ |
| Software requirements (GSPR 17) | IEC 62304 documentation | ☐ |
| Labeling (GSPR 23) | Label artwork, IFU | ☐ |
Conformity Assessment Routes
| Class | Route | NB Involvement |
|---|---|---|
| I | Annex II self-declaration | None |
| Is/Im | Annex II + IX/XI | Sterile/measuring aspects |
| IIa | Annex II + IX or XI | Product or QMS |
| IIb | Annex IX, or Annex X + XI | QMS + tech doc assessment, or type exam + production |
| III | Annex IX, or Annex X + XI | Full QMS + product dossier, or type exam + production |
Clinical Evidence
Develop clinical evidence strategy per Annex XIV:
- Define clinical claims and endpoints
- Conduct systematic literature search
- Appraise clinical data quality
- Assess equivalence (technical, biological, clinical)
- Identify evidence gaps
- Determine if clinical investigation required
- Prepare Clinical Evaluation Report (CER)
- Validation: CER reviewed by qualified evaluator
Evidence Requirements by Class
| Class | Minimum Evidence | Investigation |
|---|---|---|
| I | Risk-benefit analysis | Not typically required |
| IIa | Literature + post-market | May be required |
| IIb | Systematic literature review | Often required |
| III | Comprehensive clinical data | Required (Article 61) |
Clinical Evaluation Report Structure
CER CONTENTS
├── Executive summary
├── Device scope and intended purpose
├── Clinical background (state of the art)
├── Literature search methodology
├── Data appraisal and analysis
├── Safety and performance conclusions
├── Benefit-risk determination
└── PMCF plan summary
Qualified Evaluator Requirements
- Medical degree or equivalent healthcare qualification
- 4+ years clinical experience in relevant field
- Training in clinical evaluation methodology
- Understanding of MDR requirements
Post-Market Surveillance
Establish PMS system per Chapter VII:
- Develop PMS plan (Article 84)
- Define data collection methods
- Establish complaint handling procedures
- Create vigilance reporting process
- Plan Periodic Safety Update Reports (PSUR)
- Integrate with PMCF activities
- Define trend analysis and signal detection
- Validation: PMS system audited annually
PMS System Components
| Component | Requirement | Frequency |
|---|---|---|
| PMS Plan | Article 84 | Maintain current |
| PSUR | Article 86 — Class IIa and higher | Per Art. 86(1) schedule below |
| PMCF Plan | Annex XIV Part B | Update with CER |
| PMCF Report | Annex XIV Part B | Annual (Class III) |
| Vigilance | Articles 87-92 | As events occur |
PSUR Schedule
| Class | Frequency (MDR Art. 86(1)) |
|---|---|
| Class III | Updated at least annually |
| Class IIb (all, incl. implantable) | Updated at least annually |
| Class IIa | When necessary, at least every 2 years |
| Class I | No PSUR — PMS report instead (Art. 85) |
Serious Incident Reporting
| Timeline | Requirement |
|---|---|
| 2 days | Serious public health threat |
| 10 days | Death or serious deterioration |
| 15 days | Other serious incidents |
EUDAMED and UDI
Implement UDI system per Article 27:
- Obtain issuing entity code (GS1, HIBCC, ICCBBA)
- Assign UDI-DI to each device variant
- Assign UDI-PI (production identifier)
- Apply UDI carrier to labels (AIDC + HRI)
- Register actor in EUDAMED
- Register devices in EUDAMED
- Upload certificates when available
- Validation: UDI verified on sample labels
EUDAMED Modules
| Module | Content | Actor |
|---|---|---|
| Actor | Company registration | Manufacturer, AR |
| UDI/Device | Device and variant data | Manufacturer |
| Certificates | NB certificates | Notified Body |
| Clinical Investigation | Study registration | Sponsor |
| Vigilance | Incident reports | Manufacturer |
| Market Surveillance | Authority actions | Competent Authority |
UDI Label Requirements
Required elements per Article 13:
- UDI-DI (device identifier)
- UDI-PI (production identifier) for Class II+
- AIDC format (barcode/RFID)
- HRI format (human-readable)
- Manufacturer name and address
- Lot/serial number
- Expiration date (if applicable)
Reference Documentation
MDR Classification Guide
references/mdr-classification-guide.md contains:
- Complete Annex VIII classification rules (Rules 1-22)
- Software classification per MDCG 2019-11
- Worked classification examples
- Conformity assessment route selection
Clinical Evidence Requirements
references/clinical-evidence-requirements.md contains:
- Clinical evidence framework and hierarchy
- Literature search methodology
- Clinical Evaluation Report structure
- PMCF plan and evaluation report guidance
Technical Documentation Templates
references/technical-documentation-templates.md contains:
- Annex II and III content requirements
- Design History File structure
- GSPR compliance matrix template
- Declaration of Conformity template
- Notified Body submission checklist
Tools
MDR Gap Analyzer
# Quick gap analysis
python scripts/mdr_gap_analyzer.py --device "Device Name" --class IIa
# JSON output for integration
python scripts/mdr_gap_analyzer.py --device "Device Name" --class III --output json
# Interactive assessment
python scripts/mdr_gap_analyzer.py --interactive
Analyzes device against MDR requirements, identifies compliance gaps, generates prioritized recommendations.
Output includes:
- Requirements checklist by category
- Gap identification with priorities
- Critical gap highlighting
- Compliance roadmap recommendations
Notified Body Interface
Selection Criteria
| Factor | Considerations |
|---|---|
| Designation scope | Covers your device type |
| Capacity | Timeline for initial audit |
| Geographic reach | Markets you need to access |
| Technical expertise | Experience with your technology |
| Fee structure | Transparency, predictability |
Pre-Submission Checklist
- Technical documentation complete
- GSPR matrix fully addressed
- Risk management file current
- Clinical evaluation report complete
- QMS (ISO 13485) certified
- Labeling and IFU finalized
- Validation: Internal gap assessment complete
| 1 | |
| 2 | name "mdr-745-specialist" |
| 3 | description EU MDR 2017/745 compliance specialist for medical device classification, technical documentation, clinical evidence, and post-market surveillance. Covers Annex VIII classification rules, Annex II/III technical files, Annex XIV clinical evaluation, Art. 86 PSUR schedules, and EUDAMED integration. Use when classifying a medical device under MDR, building or gap-checking a technical file, planning clinical evaluation or PMS/PSUR cadence, or preparing for notified body review (e.g., 'what class is my device under MDR', 'review my PSUR schedule'). |
| 4 | triggers |
| 5 | - MDR compliance |
| 6 | - EU MDR |
| 7 | - medical device classification |
| 8 | - Annex VIII |
| 9 | - technical documentation |
| 10 | - clinical evaluation |
| 11 | - PMCF |
| 12 | - EUDAMED |
| 13 | - UDI |
| 14 | - notified body |
| 15 | |
| 16 | |
| 17 | # MDR 2017/745 Specialist |
| 18 | |
| 19 | EU MDR compliance patterns for medical device classification, technical documentation, and clinical evidence. |
| 20 | |
| 21 | |
| 22 | |
| 23 | ## Table of Contents |
| 24 | |
| 25 | [Device Classification Workflow] |
| 26 | [Technical Documentation] |
| 27 | [Clinical Evidence] |
| 28 | [Post-Market Surveillance] |
| 29 | [EUDAMED and UDI] |
| 30 | [Reference Documentation] |
| 31 | [Tools] |
| 32 | |
| 33 | |
| 34 | |
| 35 | ## Device Classification Workflow |
| 36 | |
| 37 | Classify device under MDR Annex VIII: |
| 38 | |
| 39 | Identify device duration (transient, short-term, long-term) |
| 40 | Determine invasiveness level (non-invasive, body orifice, surgical) |
| 41 | Assess body system contact (CNS, cardiac, other) |
| 42 | Check if active device (energy dependent) |
| 43 | Apply classification rules 1-22 |
| 44 | For software, apply MDCG 2019-11 algorithm |
| 45 | Document classification rationale |
| 46 | **Validation:** Classification confirmed with Notified Body |
| 47 | |
| 48 | ### Classification Matrix |
| 49 | |
| 50 | | Factor | Class I | Class IIa | Class IIb | Class III | |
| 51 | |--------|---------|-----------|-----------|-----------| |
| 52 | | Duration | Any | Short-term | Long-term | Long-term | |
| 53 | | Invasiveness | Non-invasive | Body orifice | Surgical | Implantable | |
| 54 | | System | Any | Non-critical | Critical organs | CNS/cardiac | |
| 55 | | Risk | Lowest | Low-medium | Medium-high | Highest | |
| 56 | |
| 57 | ### Software Classification (MDCG 2019-11) |
| 58 | |
| 59 | | Information Use | Condition Severity | Class | |
| 60 | |-----------------|-------------------|-------| |
| 61 | | Informs decision | Non-serious | IIa | |
| 62 | | Informs decision | Serious | IIb | |
| 63 | | Drives/treats | Critical | III | |
| 64 | |
| 65 | ### Classification Examples |
| 66 | |
| 67 | **Example 1: Absorbable Surgical Suture** |
| 68 | Rule 8 (implantable, long-term) |
| 69 | Duration: > 30 days (absorbed) |
| 70 | Contact: General tissue |
| 71 | Classification: **Class IIb** |
| 72 | |
| 73 | **Example 2: AI Diagnostic Software** |
| 74 | Rule 11 + MDCG 2019-11 |
| 75 | Function: Diagnoses serious condition |
| 76 | Classification: **Class IIb** |
| 77 | |
| 78 | **Example 3: Cardiac Pacemaker** |
| 79 | Rule 8 (implantable) |
| 80 | Contact: Central circulatory system |
| 81 | Classification: **Class III** |
| 82 | |
| 83 | |
| 84 | |
| 85 | ## Technical Documentation |
| 86 | |
| 87 | Prepare technical file per Annex II and III: |
| 88 | |
| 89 | Create device description (variants, accessories, intended purpose) |
| 90 | Develop labeling (Article 13 requirements, IFU) |
| 91 | Document design and manufacturing process |
| 92 | Complete GSPR compliance matrix |
| 93 | Prepare benefit-risk analysis |
| 94 | Compile verification and validation evidence |
| 95 | Integrate risk management file (ISO 14971) |
| 96 | **Validation:** Technical file reviewed for completeness |
| 97 | |
| 98 | ### Technical File Structure |
| 99 | |
| 100 | |
| 101 | ANNEX II TECHNICAL DOCUMENTATION |
| 102 | ├── Device description and UDI-DI |
| 103 | ├── Label and instructions for use |
| 104 | ├── Design and manufacturing info |
| 105 | ├── GSPR compliance matrix |
| 106 | ├── Benefit-risk analysis |
| 107 | ├── Verification and validation |
| 108 | └── Clinical evaluation report |
| 109 | |
| 110 | |
| 111 | ### GSPR Compliance Checklist |
| 112 | |
| 113 | | Requirement | Evidence | Status | |
| 114 | |-------------|----------|--------| |
| 115 | | Safe design (GSPR 1-3) | Risk management file | ☐ | |
| 116 | | Chemical properties (GSPR 10.1) | Biocompatibility report | ☐ | |
| 117 | | Infection risk (GSPR 10.2) | Sterilization validation | ☐ | |
| 118 | | Software requirements (GSPR 17) | IEC 62304 documentation | ☐ | |
| 119 | | Labeling (GSPR 23) | Label artwork, IFU | ☐ | |
| 120 | |
| 121 | ### Conformity Assessment Routes |
| 122 | |
| 123 | | Class | Route | NB Involvement | |
| 124 | |-------|-------|----------------| |
| 125 | | I | Annex II self-declaration | None | |
| 126 | | Is/Im | Annex II + IX/XI | Sterile/measuring aspects | |
| 127 | | IIa | Annex II + IX or XI | Product or QMS | |
| 128 | | IIb | Annex IX, or Annex X + XI | QMS + tech doc assessment, or type exam + production | |
| 129 | | III | Annex IX, or Annex X + XI | Full QMS + product dossier, or type exam + production | |
| 130 | |
| 131 | |
| 132 | |
| 133 | ## Clinical Evidence |
| 134 | |
| 135 | Develop clinical evidence strategy per Annex XIV: |
| 136 | |
| 137 | Define clinical claims and endpoints |
| 138 | Conduct systematic literature search |
| 139 | Appraise clinical data quality |
| 140 | Assess equivalence (technical, biological, clinical) |
| 141 | Identify evidence gaps |
| 142 | Determine if clinical investigation required |
| 143 | Prepare Clinical Evaluation Report (CER) |
| 144 | **Validation:** CER reviewed by qualified evaluator |
| 145 | |
| 146 | ### Evidence Requirements by Class |
| 147 | |
| 148 | | Class | Minimum Evidence | Investigation | |
| 149 | |-------|------------------|---------------| |
| 150 | | I | Risk-benefit analysis | Not typically required | |
| 151 | | IIa | Literature + post-market | May be required | |
| 152 | | IIb | Systematic literature review | Often required | |
| 153 | | III | Comprehensive clinical data | Required (Article 61) | |
| 154 | |
| 155 | ### Clinical Evaluation Report Structure |
| 156 | |
| 157 | |
| 158 | CER CONTENTS |
| 159 | ├── Executive summary |
| 160 | ├── Device scope and intended purpose |
| 161 | ├── Clinical background (state of the art) |
| 162 | ├── Literature search methodology |
| 163 | ├── Data appraisal and analysis |
| 164 | ├── Safety and performance conclusions |
| 165 | ├── Benefit-risk determination |
| 166 | └── PMCF plan summary |
| 167 | |
| 168 | |
| 169 | ### Qualified Evaluator Requirements |
| 170 | |
| 171 | Medical degree or equivalent healthcare qualification |
| 172 | 4+ years clinical experience in relevant field |
| 173 | Training in clinical evaluation methodology |
| 174 | Understanding of MDR requirements |
| 175 | |
| 176 | |
| 177 | |
| 178 | ## Post-Market Surveillance |
| 179 | |
| 180 | Establish PMS system per Chapter VII: |
| 181 | |
| 182 | Develop PMS plan (Article 84) |
| 183 | Define data collection methods |
| 184 | Establish complaint handling procedures |
| 185 | Create vigilance reporting process |
| 186 | Plan Periodic Safety Update Reports (PSUR) |
| 187 | Integrate with PMCF activities |
| 188 | Define trend analysis and signal detection |
| 189 | **Validation:** PMS system audited annually |
| 190 | |
| 191 | ### PMS System Components |
| 192 | |
| 193 | | Component | Requirement | Frequency | |
| 194 | |-----------|-------------|-----------| |
| 195 | | PMS Plan | Article 84 | Maintain current | |
| 196 | | PSUR | Article 86 — Class IIa and higher | Per Art. 86(1) schedule below | |
| 197 | | PMCF Plan | Annex XIV Part B | Update with CER | |
| 198 | | PMCF Report | Annex XIV Part B | Annual (Class III) | |
| 199 | | Vigilance | Articles 87-92 | As events occur | |
| 200 | |
| 201 | ### PSUR Schedule |
| 202 | |
| 203 | | Class | Frequency (MDR Art. 86(1)) | |
| 204 | |-------|-----------------------------| |
| 205 | | Class III | Updated at least annually | |
| 206 | | Class IIb (all, incl. implantable) | Updated at least annually | |
| 207 | | Class IIa | When necessary, at least every 2 years | |
| 208 | | Class I | No PSUR — PMS report instead (Art. 85) | |
| 209 | |
| 210 | ### Serious Incident Reporting |
| 211 | |
| 212 | | Timeline | Requirement | |
| 213 | |----------|-------------| |
| 214 | | 2 days | Serious public health threat | |
| 215 | | 10 days | Death or serious deterioration | |
| 216 | | 15 days | Other serious incidents | |
| 217 | |
| 218 | |
| 219 | |
| 220 | ## EUDAMED and UDI |
| 221 | |
| 222 | Implement UDI system per Article 27: |
| 223 | |
| 224 | Obtain issuing entity code (GS1, HIBCC, ICCBBA) |
| 225 | Assign UDI-DI to each device variant |
| 226 | Assign UDI-PI (production identifier) |
| 227 | Apply UDI carrier to labels (AIDC + HRI) |
| 228 | Register actor in EUDAMED |
| 229 | Register devices in EUDAMED |
| 230 | Upload certificates when available |
| 231 | **Validation:** UDI verified on sample labels |
| 232 | |
| 233 | ### EUDAMED Modules |
| 234 | |
| 235 | | Module | Content | Actor | |
| 236 | |--------|---------|-------| |
| 237 | | Actor | Company registration | Manufacturer, AR | |
| 238 | | UDI/Device | Device and variant data | Manufacturer | |
| 239 | | Certificates | NB certificates | Notified Body | |
| 240 | | Clinical Investigation | Study registration | Sponsor | |
| 241 | | Vigilance | Incident reports | Manufacturer | |
| 242 | | Market Surveillance | Authority actions | Competent Authority | |
| 243 | |
| 244 | ### UDI Label Requirements |
| 245 | |
| 246 | Required elements per Article 13: |
| 247 | |
| 248 | [ ] UDI-DI (device identifier) |
| 249 | [ ] UDI-PI (production identifier) for Class II+ |
| 250 | [ ] AIDC format (barcode/RFID) |
| 251 | [ ] HRI format (human-readable) |
| 252 | [ ] Manufacturer name and address |
| 253 | [ ] Lot/serial number |
| 254 | [ ] Expiration date (if applicable) |
| 255 | |
| 256 | |
| 257 | |
| 258 | ## Reference Documentation |
| 259 | |
| 260 | ### MDR Classification Guide |
| 261 | |
| 262 | `references/mdr-classification-guide.md` contains: |
| 263 | |
| 264 | Complete Annex VIII classification rules (Rules 1-22) |
| 265 | Software classification per MDCG 2019-11 |
| 266 | Worked classification examples |
| 267 | Conformity assessment route selection |
| 268 | |
| 269 | ### Clinical Evidence Requirements |
| 270 | |
| 271 | `references/clinical-evidence-requirements.md` contains: |
| 272 | |
| 273 | Clinical evidence framework and hierarchy |
| 274 | Literature search methodology |
| 275 | Clinical Evaluation Report structure |
| 276 | PMCF plan and evaluation report guidance |
| 277 | |
| 278 | ### Technical Documentation Templates |
| 279 | |
| 280 | `references/technical-documentation-templates.md` contains: |
| 281 | |
| 282 | Annex II and III content requirements |
| 283 | Design History File structure |
| 284 | GSPR compliance matrix template |
| 285 | Declaration of Conformity template |
| 286 | Notified Body submission checklist |
| 287 | |
| 288 | |
| 289 | |
| 290 | ## Tools |
| 291 | |
| 292 | ### MDR Gap Analyzer |
| 293 | |
| 294 | |
| 295 | # Quick gap analysis |
| 296 | python scripts/mdr_gap_analyzer.py --device "Device Name" --class IIa |
| 297 | |
| 298 | # JSON output for integration |
| 299 | python scripts/mdr_gap_analyzer.py --device "Device Name" --class III --output json |
| 300 | |
| 301 | # Interactive assessment |
| 302 | python scripts/mdr_gap_analyzer.py --interactive |
| 303 | |
| 304 | |
| 305 | Analyzes device against MDR requirements, identifies compliance gaps, generates prioritized recommendations. |
| 306 | |
| 307 | **Output includes:** |
| 308 | Requirements checklist by category |
| 309 | Gap identification with priorities |
| 310 | Critical gap highlighting |
| 311 | Compliance roadmap recommendations |
| 312 | |
| 313 | |
| 314 | |
| 315 | ## Notified Body Interface |
| 316 | |
| 317 | ### Selection Criteria |
| 318 | |
| 319 | | Factor | Considerations | |
| 320 | |--------|----------------| |
| 321 | | Designation scope | Covers your device type | |
| 322 | | Capacity | Timeline for initial audit | |
| 323 | | Geographic reach | Markets you need to access | |
| 324 | | Technical expertise | Experience with your technology | |
| 325 | | Fee structure | Transparency, predictability | |
| 326 | |
| 327 | ### Pre-Submission Checklist |
| 328 | |
| 329 | [ ] Technical documentation complete |
| 330 | [ ] GSPR matrix fully addressed |
| 331 | [ ] Risk management file current |
| 332 | [ ] Clinical evaluation report complete |
| 333 | [ ] QMS (ISO 13485) certified |
| 334 | [ ] Labeling and IFU finalized |
| 335 | [ ] **Validation:** Internal gap assessment complete |
| 336 |
Discussion
Browse more free Claude skills.